Home > News > Altair's Thin Coating
April 27th, 2007
Altair's Thin Coating
Abstract:
A few weeks ago, I wrote about how Behr's Premium Plus Ultra paint now uses Nanophase Technologies' (Nasdaq: NANX) proprietary nanoparticles. That news makes the $134 million nanotech company look like a solid, if not spectacular, investment.
You might think I'd be similarly bullish about word from Altair Nanotechnologies (Nasdaq: ALTI) that it's teamed up with leading paint manufacturer Sherwin-Williams (NYSE: SHW) to form a new company, AlSher Titania. All things being equal, it would be a step in the right direction for Altair; but as I've often said before, when it comes to this company, all things are not equal.
First off, Altair claims that AlSher Titania will be able to produce titanium dioxide pigment at a significantly lower price point than rivals. I find this a little hard to believe, especially since BASF (NYSE: BF) and Millennium Chemical (a subsidiary of the Lyondell Company (NYSE: LYO) are among the largest producers of titanium dioxide. On relative economies of scale alone, it's difficult to imagine how Altair's small manufacturing facility could match these behemoths on cost.
Source:
fool.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||